Correspondence 0001104659-23-116219 from PaxMedica, Inc. (PXMD) (CIK 0001811623)
PaxMedica, Inc. (PXMD) (CIK 0001811623)
Date: Nov. 9, 2023 · CIK: 0001811623 · Accession: 0001104659-23-116219
AI Filing Summary & Sentiment
File numbers found in text: 333-275416
Letter
VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Doris Stacey Gama Re: PaxMedica, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-275416
Dear Ms. Gama,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to November 13, 2023, at 5:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling Anna Tomczyk at (212) 641-5626 or Austin Day at (704) 339-3159.
If you have any questions regarding this request, please contact Anna Tomczyk of Dechert LLP at (212) 641-5626.
Sincerely,
PAXMEDICA, INC.
Show Raw Text
CORRESP
1
filename1.htm
November 9, 2023
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Doris Stacey Gama
Re:
PaxMedica, Inc.
Acceleration Request for Registration Statement on Form S-1
File No. 333-275416
Dear Ms. Gama,
Pursuant to Rule 461
under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby
requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated
to November 13, 2023, at 5:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP,
request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the
Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement
is effective, please orally confirm the event with our counsel, Dechert LLP, by calling Anna Tomczyk at (212) 641-5626 or Austin Day at
(704) 339-3159.
If you have any questions
regarding this request, please contact Anna Tomczyk of Dechert LLP at (212) 641-5626.
Sincerely,
PAXMEDICA, INC.
/s/ Howard Weisman
Howard Weisman
Chief Executive Officer
cc:
Anna Tomczyk, Dechert LLP